Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine

Thomas G. Beach, Yu Min Kuo, Claudia Schwab, Douglas G. Walker, Alex E. Roher

研究成果: Article同行評審

30 引文 斯高帕斯(Scopus)

摘要

Overproduction of the peptide amyloid β (Aβ) is thought to be a critical pathogenetic event in Alzheimer's disease (AD). Decreasing Aβ production may therefore slow or halt the progression of AD. In vitro work has indicated that cholinergic muscarinic receptor agonists may reduce cellular production of Aβ. Here we show that systemic administration of physostigmine, an acetylcholinesterase inhibitor, lowers Aβ levels in vivo. Guinea pigs treated for 10 days with s.c. physostigmine had levels of cortical AβN-40 and N-42 which were 57% and 72%, respectively, of those in control animals. Levels of cortical β-amyloid precursor protein were not significantly affected by drug treatment. These results suggest that cholinergic therapy may affect the course of AD by limiting Aβ accumulation.

原文English
頁(從 - 到)21-24
頁數4
期刊Neuroscience Letters
310
發行號1
DOIs
出版狀態Published - 2001 九月 7

All Science Journal Classification (ASJC) codes

  • 神經科學 (全部)

指紋

深入研究「Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine」主題。共同形成了獨特的指紋。

引用此